To provide community pharmacists with up-to-date information regarding their role
in the diagnosis and treatment of patients with venous thromboembolism and acute
This activity is designed for community pharmacists. No prerequisites required.
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
- Describe the clinical features, diagnosis, management, and prophylaxis of acute coronary syndrome (ACS) and venous thromboembolism (VTE).
- Discuss the most current outpatient management strategies for ACS and VTE and the community pharmacist's role in pharmacologic and nonpharmacologic management.
- Devise and implement measures aimed at improving patient compliance with national guideline therapies and ensure that patients are receiving these guideline treatments.
- Evaluate drug-specific (eg, adverse effects and drug interactions) and other considerations (eg, pharmacoeconomics and insurance formulary) when selecting agents for the treatment of ACS and VTE.
- Review strategies to strengthen the collaboration of various healthcare disciplines in promoting quality improvement in the care of patients with ACS and VTE.
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for pharmacists.
CREDIT DESIGNATION STATEMENT
This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy, which is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Program # 064-000-07-215-H01-P
This continuing education activity was produced under the supervision of
Glen E. Farr, PharmD, Associate Dean of Continuing Pharmacy Education, University of Tennessee College of Pharmacy.
The estimated time to complete this educational activity: 2 hours.
Release date: October 15, 2007. Expiration date: October 15, 2009.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
This program is supported by an educational grant from GlaxoSmithKline.